MovDisordV3, PascalFrancis, Checkpoint, bibRecord, 001D01

Swallowing abnormalities and dyskinesia in Parkinson's disease

Identifieur interne : 001D01 ( PascalFrancis/Checkpoint ); précédent : 001D00; suivant : 001D02

Swallowing abnormalities and dyskinesia in Parkinson's disease

Auteurs : Francisca Sueli Monte [Brésil] ; Francisco Pereira Da Silva-Junior [Brésil] ; Pedro Braga-Neto [Brésil] ; Miguel Angelo Nobre E Souza [Brésil] ; Veralice Meireles Sales De Bruin [Brésil]

Source :

Movement disorders [ 0885-3185 ] ; 2005.

RBID : Pascal:05-0262067

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Déglutition, Lévodopa, Dyskinésie, Parkinson maladie, Dysphagie.

English descriptors

KwdEn :
- Dyskinesia, Dysphagia, Levodopa, Nervous system diseases, Parkinson disease, Swallowing.

Abstract

Gastrointestinal abnormalities in Parkinson's disease (PD) have been known for almost two centuries, but many aspects concerning their pathophysiology have not been completely clarified. The aim of this study was to characterize the oropharyngeal dynamics in PD patients with and without levodopa-induced dyskinesia. Fifteen dyskinetic patients, 12 nondyskinetic patients, and a control group were included. Patients were asked about dysphagia and evaluated with the Unified Parkinson's Disease Rating Scale Parts II and III and the Hoehn and Yahr scale. Deglutition was assessed using modified barium swallow with videofluoroscopy. Nondyskinetic patients, but not the dyskinetic ones, showed less oropharyngeal swallowing efficiency (OPSE) for liquid food than controls (Dunnett, P = 0.02). Dyskinetic patients tended to have a greater OPSE than nondyskinetic (Dunnett, P = 0.06). Patients who were using a higher dose of levodopa had a greater OPSE and a trend toward a smaller oral transit time (Pearson's correlation, P = 0.01 and 0.08, respectively). Neither the report of dysphagia nor any of the PD severity parameters correlated to the videofluoroscopic variables. In the current study, dyskinetic patients performed better in swallowing function, which could be explained on the basis of a greater levodopa dose. Our results suggest a role for levodopa in the oral phase of deglutition and confirm that dysphagia is not a good predictor of deglutition alterations in PD.

Affiliations:

Brésil

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 001F06
to stream PascalFrancis, to step Curation: 000E15

Links to Exploration step

Pascal:05-0262067

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Swallowing abnormalities and dyskinesia in Parkinson's disease</title>
<author><name sortKey="Monte, Francisca Sueli" sort="Monte, Francisca Sueli" uniqKey="Monte F" first="Francisca Sueli" last="Monte">Francisca Sueli Monte</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacy, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Pharmacy, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Da Silva Junior, Francisco Pereira" sort="Da Silva Junior, Francisco Pereira" uniqKey="Da Silva Junior F" first="Francisco Pereira" last="Da Silva-Junior">Francisco Pereira Da Silva-Junior</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Clinical Medicine, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Clinical Medicine, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Braga Neto, Pedro" sort="Braga Neto, Pedro" uniqKey="Braga Neto P" first="Pedro" last="Braga-Neto">Pedro Braga-Neto</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Clinical Medicine, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Clinical Medicine, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nobre E Souza, Miguel Angelo" sort="Nobre E Souza, Miguel Angelo" uniqKey="Nobre E Souza M" first="Miguel Angelo" last="Nobre E Souza">Miguel Angelo Nobre E Souza</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Clinical Medicine, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Clinical Medicine, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Bruin, Veralice Meireles Sales" sort="De Bruin, Veralice Meireles Sales" uniqKey="De Bruin V" first="Veralice Meireles Sales" last="De Bruin">Veralice Meireles Sales De Bruin</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Clinical Medicine, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Clinical Medicine, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">05-0262067</idno>
<date when="2005">2005</date>
<idno type="stanalyst">PASCAL 05-0262067 INIST</idno>
<idno type="RBID">Pascal:05-0262067</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001F06</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000E15</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001D01</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Swallowing abnormalities and dyskinesia in Parkinson's disease</title>
<author><name sortKey="Monte, Francisca Sueli" sort="Monte, Francisca Sueli" uniqKey="Monte F" first="Francisca Sueli" last="Monte">Francisca Sueli Monte</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Pharmacy, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Pharmacy, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Da Silva Junior, Francisco Pereira" sort="Da Silva Junior, Francisco Pereira" uniqKey="Da Silva Junior F" first="Francisco Pereira" last="Da Silva-Junior">Francisco Pereira Da Silva-Junior</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Clinical Medicine, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Clinical Medicine, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Braga Neto, Pedro" sort="Braga Neto, Pedro" uniqKey="Braga Neto P" first="Pedro" last="Braga-Neto">Pedro Braga-Neto</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Clinical Medicine, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Clinical Medicine, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Nobre E Souza, Miguel Angelo" sort="Nobre E Souza, Miguel Angelo" uniqKey="Nobre E Souza M" first="Miguel Angelo" last="Nobre E Souza">Miguel Angelo Nobre E Souza</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Clinical Medicine, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Clinical Medicine, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Bruin, Veralice Meireles Sales" sort="De Bruin, Veralice Meireles Sales" uniqKey="De Bruin V" first="Veralice Meireles Sales" last="De Bruin">Veralice Meireles Sales De Bruin</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Clinical Medicine, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Brésil</country>
<wicri:noRegion>Department of Clinical Medicine, Federal University of Ceard</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2005">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dyskinesia</term>
<term>Dysphagia</term>
<term>Levodopa</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Swallowing</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Déglutition</term>
<term>Lévodopa</term>
<term>Dyskinésie</term>
<term>Parkinson maladie</term>
<term>Dysphagie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Gastrointestinal abnormalities in Parkinson's disease (PD) have been known for almost two centuries, but many aspects concerning their pathophysiology have not been completely clarified. The aim of this study was to characterize the oropharyngeal dynamics in PD patients with and without levodopa-induced dyskinesia. Fifteen dyskinetic patients, 12 nondyskinetic patients, and a control group were included. Patients were asked about dysphagia and evaluated with the Unified Parkinson's Disease Rating Scale Parts II and III and the Hoehn and Yahr scale. Deglutition was assessed using modified barium swallow with videofluoroscopy. Nondyskinetic patients, but not the dyskinetic ones, showed less oropharyngeal swallowing efficiency (OPSE) for liquid food than controls (Dunnett, P = 0.02). Dyskinetic patients tended to have a greater OPSE than nondyskinetic (Dunnett, P = 0.06). Patients who were using a higher dose of levodopa had a greater OPSE and a trend toward a smaller oral transit time (Pearson's correlation, P = 0.01 and 0.08, respectively). Neither the report of dysphagia nor any of the PD severity parameters correlated to the videofluoroscopic variables. In the current study, dyskinetic patients performed better in swallowing function, which could be explained on the basis of a greater levodopa dose. Our results suggest a role for levodopa in the oral phase of deglutition and confirm that dysphagia is not a good predictor of deglutition alterations in PD.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>20</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Swallowing abnormalities and dyskinesia in Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>MONTE (Francisca Sueli)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DA SILVA-JUNIOR (Francisco Pereira)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>BRAGA-NETO (Pedro)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>NOBRE E SOUZA (Miguel Angelo)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>DE BRUIN (Veralice Meireles Sales)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Pharmacy, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Clinical Medicine, Federal University of Ceard</s1>
<s3>BRA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>457-462</s1>
</fA20>
<fA21><s1>2005</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000124582390090</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2005 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>31 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>05-0262067</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Gastrointestinal abnormalities in Parkinson's disease (PD) have been known for almost two centuries, but many aspects concerning their pathophysiology have not been completely clarified. The aim of this study was to characterize the oropharyngeal dynamics in PD patients with and without levodopa-induced dyskinesia. Fifteen dyskinetic patients, 12 nondyskinetic patients, and a control group were included. Patients were asked about dysphagia and evaluated with the Unified Parkinson's Disease Rating Scale Parts II and III and the Hoehn and Yahr scale. Deglutition was assessed using modified barium swallow with videofluoroscopy. Nondyskinetic patients, but not the dyskinetic ones, showed less oropharyngeal swallowing efficiency (OPSE) for liquid food than controls (Dunnett, P = 0.02). Dyskinetic patients tended to have a greater OPSE than nondyskinetic (Dunnett, P = 0.06). Patients who were using a higher dose of levodopa had a greater OPSE and a trend toward a smaller oral transit time (Pearson's correlation, P = 0.01 and 0.08, respectively). Neither the report of dysphagia nor any of the PD severity parameters correlated to the videofluoroscopic variables. In the current study, dyskinetic patients performed better in swallowing function, which could be explained on the basis of a greater levodopa dose. Our results suggest a role for levodopa in the oral phase of deglutition and confirm that dysphagia is not a good predictor of deglutition alterations in PD.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B02U01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Déglutition</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Swallowing</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Deglutición</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Lévodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Levodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Levodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Dyskinésie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dyskinesia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Disquinesia</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Dysphagie</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Dysphagia</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Disfagia</s0>
<s5>10</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Appareil digestif pathologie</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Digestive diseases</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Aparato digestivo patología</s0>
<s5>43</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Oesophage pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Esophageal disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Esófago patología</s0>
<s5>45</s5>
</fC07>
<fN21><s1>185</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
<affiliations><list><country><li>Brésil</li>
</country>
</list>
<tree><country name="Brésil"><noRegion><name sortKey="Monte, Francisca Sueli" sort="Monte, Francisca Sueli" uniqKey="Monte F" first="Francisca Sueli" last="Monte">Francisca Sueli Monte</name>
</noRegion>
<name sortKey="Braga Neto, Pedro" sort="Braga Neto, Pedro" uniqKey="Braga Neto P" first="Pedro" last="Braga-Neto">Pedro Braga-Neto</name>
<name sortKey="Da Silva Junior, Francisco Pereira" sort="Da Silva Junior, Francisco Pereira" uniqKey="Da Silva Junior F" first="Francisco Pereira" last="Da Silva-Junior">Francisco Pereira Da Silva-Junior</name>
<name sortKey="De Bruin, Veralice Meireles Sales" sort="De Bruin, Veralice Meireles Sales" uniqKey="De Bruin V" first="Veralice Meireles Sales" last="De Bruin">Veralice Meireles Sales De Bruin</name>
<name sortKey="Nobre E Souza, Miguel Angelo" sort="Nobre E Souza, Miguel Angelo" uniqKey="Nobre E Souza M" first="Miguel Angelo" last="Nobre E Souza">Miguel Angelo Nobre E Souza</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D01 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 001D01 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:05-0262067
   |texte=   Swallowing abnormalities and dyskinesia in Parkinson's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Swallowing abnormalities and dyskinesia in Parkinson's disease

Swallowing abnormalities and dyskinesia in Parkinson's disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri